Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call
August 13, 2025 11:45 ET Â | Source: Milestone Scientific, Inc. ROSELAND, N.J.,…
CAS SciFinder integrates transformative new science-smart AI capabilities to enhance R&D efficiency and boost innovation
Pioneering solution provides scientists with actionable answers faster to accelerate scientific discovery…
Citryll Announces Formation of Scientific Advisory Board
July 24, 2025 02:00 ET Â | Source: Citryll CITRYLL ANNOUNCES FORMATION OF…
The 2025 International Congress of Basic Science Opens in Beijing
BEIJING, July 22, 2025 /PRNewswire/ -- The 2025 International Congress of Basic…
Life Biosciences Announces Research Collaboration with SingHealth Duke-NUS Regenerative Medicine Institute of Singapore (REMEDIS) to Expand Pipeline of Cellular Rejuvenation Therapies
Collaboration in Singapore aims to further expand the broad potential of Life…
J.S. Held Expert Teams’ Work Across Six Continents Recognized as Industry Leading
JERICHO, N.Y., July 17, 2025 /PRNewswire/ -- Global consulting firm J.S. Held…
Bridge Capture enables sensitive, scalable liquid biopsy in colorectal cancer pilot
Clinical study in Scientific Reports shows Bridge Captureâ„¢ detects key mutations from…
Metabolon Announces a Quarter Century of Scientific Innovation, Industry Leadership, and Transformative Contributions to Life Science
A recognized pioneer in metabolomics, Metabolon is the most experienced and trusted…
B612 Foundation Announces Winner of Prestigious Schweickart Prize: Imperial College London’s Jordan Stone Leads Winning Proposal for International Panel on Asteroid Orbit Alteration, Recognized for its Foresight in Planetary Defense
SAN FRANCISCO, June 26, 2025 /PRNewswire/ --Â B612 Foundation today announced the recipient…
Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance
ROCKVILLE, Md. and SUZHOU, China, July 07, 2025 (GLOBE NEWSWIRE) -- Ascentage…